By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genetic Immunity 

8300 Greensboro Drive
Suite 800
McLean  Virginia  22102  U.S.A.
Phone: 703-883-0312 Fax: n/a


Company News
Genetic Immunity Receives GMP Certification for in-House Manufacturing Facility 10/8/2012 9:14:19 AM
Genetic Immunity Clinical Trial Data Published in PLoS ONE 5/17/2012 9:44:46 AM
Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference 12/9/2010 8:39:08 AM
Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naive Individuals 7/19/2010 9:39:35 AM
Immunacia's Genetic Immunity Presents DermaVir at the 7th International Conference on Nanosciences & Nanotechnologies – A Unique Nanomedicine for Therapeutic HIV Vaccine 7/12/2010 8:33:49 AM
Genetic Immunity Develops Unique Nanomedicine Formulation for DermaVir Therapeutic Vaccine for HIV/AIDS 5/13/2010 9:03:57 AM
Dr. James Chafouleas Joins ViroStatics and Genetic Immunity as Strategic Adviser 5/3/2010 3:17:56 PM
Genetic Immunity Presents DermaVir at DNA Vaccines 2010 Conference – Unique Nanomedicine Formulation and Topical Administration of an HIV/AIDS Therapeutic Vaccine 3/2/2010 3:36:45 PM
Genetic Immunity, InPlay: Company Completes Patient Enrollment in Italian Phase II Trial of DermaVir Patch HIV Immunotherapeutic Nanomedicine 7/1/2009 9:48:49 AM
Genetic Immunity: Company to Present at Phacilitate Ltd's 8th Annual European Vaccine Forum 6/18/2009 9:51:48 AM